EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency

Te Liu, Runkai Zhao, Heng Zhang, Guoqiang Zhang, Jun Fu, Ming Ni

The Journal of Arthroplasty · 2025

DOI: 10.1016/j.arth.2025.08.010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Te Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China; Chinese Academy of Medical Sciences and Peking Un…. Hauptthemen laut MEDLINE: Cefuroxime, Arthroplasty, Replacement, Knee, Anti-Bacterial Agents, Antibiotic Prophylaxis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intraosseous regional administration (IORA) of vancomycin for preventing infection in total knee arthroplasty (TKA) achieves high local tissue concentrations and enhances efficacy when combined with intravenous (IV) cephalosporins. This study evaluated the safety and efficacy of standalone intraosseous (IO) cefuroxime for TKA infection prophylaxis and determined its optimal dose. METHODS: There were 30 primary TKA patients divided into three groups: IO administration of 750 mg cefuroxime (C750IO group), IO administration of 1,500 mg cefuroxime (C1500IO group), and IV administration of 1,500 mg cefuroxime (C1500IV group). All groups received no other IV antibiotics preoperatively. During surgery, nine tissue samples were collected: bone samples were collected from the femur or tibia, synovial and fat samples were collected from the surgical area, and systemic blood samples were collected twice to detect cefuroxime levels. Intraoperative vital signs, inflammatory markers, and liver/kidney function on days one and three, and postoperative and complications within three months were recorded. RESULTS: The C750IO and C1500IO groups showed higher tissue cefuroxime concentrations than the C1500IV group (P 0.05). Intraoperative blood concentrations were lower in the IO groups compared to C1500IV (P 0.05). Postoperative inflammatory marker levels were higher in the C1500IV group than in the C750IO and C1500IO groups, with significantly lower erythrocyte sedimentation rate levels in the C750IO group on postoperative day three compared to the C1500IV group (P = 0.017). No infections or adverse drug events occurred within three months postoperatively. CONCLUSIONS: Intraosseous cefuroxime (750 or 1500 mg) achieved higher local tissue concentrations than IV 1,500 mg in TKA. Preoperative IO 750 mg cefuroxime alone minimized systemic exposure while maintaining effective concentrations, suggesting its safety and potential as a preferred prophylactic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefuroximeArthroplasty, Replacement, KneeAnti-Bacterial AgentsAntibiotic ProphylaxisProsthesis-Related InfectionsHumansFemaleMaleAgedInfusions, IntraosseousMiddle AgedSecond Generation CephalosporinsPreoperative CareTreatment OutcomeAged, 80 and overSurgical Wound Infection

Stichwörter der Autor:innen

cefuroximeintraosseous regional administration (IORA)periprosthetic joint infection (PJI)prophylactic antibioticstotal knee arthroplasty (TKA)

Substanzen

CefuroximeAnti-Bacterial AgentsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China; The First Affiliated Hospital of Henan Medical University, Xinxiang, China.
  • Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China; Department of Orthopedics, The First Medical Center, Chinese PLA General…
  • Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China; Department of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Liu, T., Zhao, R., Zhang, H., Zhang, G., Fu, J., & Ni, M. (2025). Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2025.08.010

Vancouver

Liu T, Zhao R, Zhang H, Zhang G, Fu J, Ni M. Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2025.08.010

BibTeX
@article{Liu2025,
  author = {Liu, Te and Zhao, Runkai and Zhang, Heng and Zhang, Guoqiang and Fu, Jun and Ni, Ming},
  title = {Preoperative Stand-Alone Intraosseous Cefuroxime in Total Knee Arthroplasty: A Randomized Trial Demonstrating Superior Tissue Concentrations and Improved Efficiency},
  journal = {The Journal of Arthroplasty},
  year = {2025},
  doi = {10.1016/j.arth.2025.08.010}
}
Kostenlos starten →